What is acute myeloid leukaemia?
Acute myeloid leukaemia (AML) is a type of cancer that affects the blood and bone marrow.
What causes acute myeloid leukaemia?
The exact cause of acute myeloid leukaemia is not known. However, certain factors, such as exposure to radiation and certain chemicals, can increase the risk of developing this cancer.
What are the symptoms of acute myeloid leukaemia?
The symptoms of acute myeloid leukaemia include fatigue, weakness, easy bruising or bleeding, fever, and frequent infections.
What are some possible treatments for acute myeloid leukaemia?
Some possible treatments for acute myeloid leukaemia include chemotherapy, radiation therapy, and stem cell transplantation.
What is the survival rate for acute myeloid leukaemia?
The survival rate for acute myeloid leukaemia varies depending on factors such as the age of the patient, the stage of the cancer, and the overall health of the patient. The five-year survival rate is around 27 percent.
What is the definition of acute myeloid leukaemia?
Acute myeloid leukaemia is a cancer that affects the blood and bone marrow, causing an overproduction of immature white blood cells.
What is the functional genomic landscape of acute myeloid leukaemia?
The functional genomic landscape of acute myeloid leukaemia refers to the genetic alterations and changes in gene expression that drive the development and progression of this cancer.
What is the acute myeloid leukaemia therapeutics market?
The acute myeloid leukaemia therapeutics market refers to the pharmaceutical industry that develops and markets drugs and treatments for this cancer.
What are some statistics about acute myeloid leukaemia?
Acute myeloid leukaemia affects around 20,000 people in the US each year. The five-year survival rate is around 27 percent.
What is acute myeloid leukaemia UK?
Acute myeloid leukaemia UK refers to the incidence, diagnosis, and treatment of this cancer in the United Kingdom.
What is the prognosis for acute myeloid leukaemia?
The prognosis for acute myeloid leukaemia varies depending on factors such as the age of the patient, the stage of the cancer, and the overall health of the patient. The five-year survival rate is around 27 percent.
Can the risk of acute myeloid leukaemia be predicted in healthy individuals?
There are some methods for predicting the risk of acute myeloid leukaemia in healthy individuals, such as genetic testing and analysis of environmental factors that increase the risk of developing this cancer.
What is acute myeloid leukaemia patient UK?
Acute myeloid leukaemia patient UK is a support and advocacy group for patients and families affected by this cancer in the United Kingdom.
How is acute myeloid leukaemia diagnosed?
Acute myeloid leukaemia is diagnosed through a combination of blood tests, bone marrow biopsy, and imaging tests such as X-rays and CT scans.
What is acute myeloid leukaemia NZ?
Acute myeloid leukaemia NZ refers to the incidence, diagnosis, and treatment of this cancer in New Zealand.
What are acute myeloid leukaemia pathology outlines?
Acute myeloid leukaemia pathology outlines refer to the microscopic examination of biopsy samples to determine the characteristics of the cancer and to guide treatment decisions.
What is the first line treatment for acute myeloid leukaemia?
Chemotherapy is the first line treatment for most cases of acute myeloid leukaemia.
What is the latest research in acute myeloid leukaemia in 2018?
The latest research in acute myeloid leukaemia focuses on the molecular mechanisms of the cancer and the development of targeted therapies to treat specific subtypes of the cancer.
What are Auer rods in acute myeloid leukaemia?
Auer rods are needle-like structures that are seen in the cytoplasm of immature white blood cells in acute myeloid leukaemia.
What are the common risk factors for acute myeloid leukaemia?
Some common risk factors for acute myeloid leukaemia include age (generally over 65), previous chemotherapy or radiation therapy, exposure to certain chemicals, and genetic disorders such as Down syndrome.
What are the potential side effects of chemotherapy for acute myeloid leukaemia?
Chemotherapy for acute myeloid leukaemia can cause a range of side effects, including nausea, vomiting, hair loss, fatigue, and increased risk of infection.
What is targeted therapy for acute myeloid leukaemia?
Targeted therapy for acute myeloid leukaemia uses drugs that target specific molecules or pathways that are involved in the growth and survival of the cancer cells.
What is the role of stem cell transplantation in treating acute myeloid leukaemia?
Stem cell transplantation is used in some cases of acute myeloid leukaemia to replace damaged bone marrow with healthy stem cells.
What is the relationship between acute myeloid leukaemia and myelodysplastic syndrome?
Myelodysplastic syndrome is a group of disorders characterized by abnormal blood cell formation. Some people with myelodysplastic syndrome may develop acute myeloid leukaemia over time.
What is the role of radiation therapy in treating acute myeloid leukaemia?
Radiation therapy is sometimes used in combination with chemotherapy to treat acute myeloid leukaemia. It may be used to target cancer cells that have spread to other parts of the body, such as the brain or spinal cord.
Is acute myeloid leukaemia curable?
Acute myeloid leukaemia is a difficult cancer to cure, but some patients can achieve long-term remission with aggressive treatment.
What are some of the challenges in developing effective treatments for acute myeloid leukaemia?
Some of the challenges in developing effective treatments for acute myeloid leukaemia include the complexity of the disease, the heterogeneity of the cancer cells, and the development of resistance to chemotherapy and other treatments.
What is the latest research in acute myeloid leukaemia in 2021?
The latest research in acute myeloid leukaemia in 2021 focuses on the development of new targeted therapies, the identification of new genetic markers of the disease, and the development of strategies to overcome resistance to chemotherapy.
What is the role of clinical trials in developing new treatments for acute myeloid leukaemia?
Clinical trials play a critical role in developing new treatments for acute myeloid leukaemia. These trials test the safety and efficacy of new drugs and treatment strategies, and can lead to the development of new standards of care for patients with this cancer.
Log in 
